Introduction
Late onset Alzheimer's disease, a neurodegenerative condition characterized by large numbers of senile plaques and neurofibrillary tangles in the brain, is the most common cause of dementia in the elderly. Multiple rare mutations in the APP, PSEN1
and PSEN2 genes cause an early onset familial form of the disease (for review see ref. 1 ), and twin studies indicate that susceptibility alleles may contribute as much as 80% to the risk of late-onset AD (LOAD). 2 Until recently, however, APOE 4 was the only allele reliably associated with increased susceptibility to LOAD. [3] [4] [5] A robust technology has emerged that permits genome-wide association studies (GWAS) of large numbers of subjects. This technology has enabled the identification of relatively weak associations that would otherwise go undetected.
Recently Harold et al. 6 and Lambert et al. 7 published the two largest LOAD GWAS conducted to date and reported genome-wide significant association with three novel LOAD genes. The first study, by Harold et 
DNA isolation
For the JS and RS samples, DNA was isolated from whole blood using an
AutoGen instrument (AutoGen, Inc, Holliston, MA). The DNA from AUT samples was extracted from cerebellum using Wizard® Genomic DNA Purification Kits (Promega Corp., Madison, WI). DNA from the RS and AUT series was scarce, so samples from these two series were subjected to whole genome amplification using the Illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare Bio-Sciences Corp., Piscataway, NJ).
Genotyping
All genotyping was performed at the Mayo Clinic in Jacksonville using TaqMan® SNP Genotyping Assays in an ABI PRISM® 7900HT Sequence Detection System with 384-Well Block Module from Applied Biosystems, California, USA. The genotype data was analyzed using the SDS software version 2.2.3 (Applied Biosystems, California, USA).
Statistical Analyses
For the analysis of the Mayo series, an allelic dosage model using logistic regression adjusted by sex and APOE ε4 status was used to generate p values and odds ratios for the association of LOAD with the minor allele. The results reported in the two original GWAS papers by Harold et al. 6 and Lambert et al. 7 were also generated using logistic regression analyses assuming an additive model to test for association with the minor allele. However, the covariates used differed between the three studies. 
Results
We genotyped the most significant SNP in each of the three genes reported by
Harold et al. 6 , and Lambert et al. 7 , to determine if the associations could be detected in our follow-up series. Remarkably, the direction and magnitude of each association replicated well in our series and addition of our follow-up data to the results previously reported increased the strength of evidence (Fisher's combined summary statistic) for each of the associations ( Table 1 
Comment
For over 15 years, APOE alleles were the only genetic variants that showed replicable association with altered susceptibility to LOAD. Over 500 additional candidate genes were investigated in more than 1,200 studies, 9 but little progress was made until the last several years when large LOAD case-control series and meta-analyses were employed to gain the power necessary to detect associations much weaker than those of the APOE alleles. Except for the three genes pursued in this manuscript, the most significant evidence for a novel LOAD gene comes from the two-stage GWAS of Carrasquillo et al. 10 , who found impressive association of PCDH11X (rs2573905) with LOAD (p = 5.4x10 -13 ) in their two-stage GWAS of seven case-control series with a combined total of 5,010 subjects. The AlzGene website maintained by Bertram and Tanzi, which summarizes genetic association studies of LOAD, currently lists 35 loci (as of November 2009) with one or several variants that are nominally significant when tested for allelic association in random-effects meta-analyses. 11 Some of these were identified using a candidate gene approach, others in the eleven LOAD GWAS (e.g.
CLU, CR1, PICALM, and GAB2) that have been performed to date (for review see
Bertram and Tanzi. 9 ) SORL1, which directs Aß away from the Aß-generating pathway and was discovered using a candidate gene approach, 12 shows particularly impressive association with several variants that associate with LOAD in multiple, large case-control series. The association for many of the other candidate genes is based on relatively few subjects, shows substantial heterogeneity from series, or is weak. Thus many of the nominally significant associations for candidate genes are tenuous and require additional replication.
Genome-wide association studies often give inflated ORs that are substantially reduced in follow-up series. In this first, independent follow-up analysis of CLU, CR1, and PICALM, this was not the case, as we obtained ORs that were essentially identical to those observed in the initial studies. Thus our findings provide strong additional evidence that all three genes are novel LOAD genes. CLU (aka APOJ) encodes clusterin which interacts with Aß 13-16 and appears to influence the aggregation and toxicity of this important AD-related peptide. [17] [18] [19] [20] CR1 encodes the major receptor of C3b, a protein involved in complement activation, and could mediate complement-driven phagocytosis that fosters Aß clearance (for summary see ref.
7
). PICALM (aka CALM) encodes phosphatidylinositol-binding clathrin assembly protein which is involved in clathrinmediated endocytosis, 21, 22 a process that could alter risk for AD through an effect on synaptic transmission or by altering endocytosis of the amyloid beta protein precursor.
Thus all three new genes afford good opportunities for pursuit in biological experiments aimed at identifying novel approaches to the therapy of AD.
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